Use of inotuzumab-ozogamicin in a child with Down syndrome and refractory B-cell precursor acute lymphoblastic leukemia

Pediatr Blood Cancer. 2019 Apr;66(4):e27562. doi: 10.1002/pbc.27562. Epub 2018 Nov 28.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adolescent
  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Down Syndrome / drug therapy*
  • Down Syndrome / pathology
  • Humans
  • Inotuzumab Ozogamicin
  • Male
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / pathology

Substances

  • Antibodies, Monoclonal, Humanized
  • Inotuzumab Ozogamicin